IperionX Limited (IPX)
NASDAQ: IPX
· Real-Time Price · USD
39.72
0.61 (1.56%)
At close: Aug 14, 2025, 3:59 PM
42.05
5.87%
Pre-market: Aug 15, 2025, 09:08 AM EDT
IperionX Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.25 | 13.70 | 13.70 |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.62 | 6.85 | 6.85 |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.62 | 6.85 | 6.85 |
Operating Income | -33.04K | -27.83K | -22.62K | -20.86K | -19.1K | -18.38K | -17.66K | -18.76K | -19.85K | -20.86K | -21.87K | -16.97K | -12.08K | -6.86K | -1.62K | -1.1K |
Interest Income | n/a | 74.46 | 148.92 | 335.74 | 521.87 | 570.48 | 627.01 | 551.65 | 476.99 | 420.73 | 356.53 | 245.13 | 133.72 | 69.39 | 4.79 | 9.50 |
Pretax Income | -27.59K | -24.71K | -21.84K | -20.51K | -19.19K | -18.32K | -17.44K | -18.58K | -19.71K | -20.62K | -21.52K | -19.3K | -17.09K | -11.92K | -6.73K | -3.64K |
Net Income | -27.59K | -24.71K | -21.84K | -20.51K | -19.19K | -18.32K | -17.44K | -18.58K | -19.71K | -20.62K | -21.52K | -19.3K | -17.09K | -11.92K | -6.73K | -3.64K |
Selling & General & Admin | 21.28K | 17.59K | 13.9K | 12.87K | 11.84K | 11.95K | 12.06K | 14.72K | 17.37K | 19.08K | 20.79K | 16.09K | 11.38K | 6.51K | 1.62K | 1.09K |
Research & Development | 11.76K | 10.24K | 8.71K | 7.99K | 7.26K | 6.43K | 5.6K | 4.04K | 2.48K | 1.78K | 1.08K | 887.91 | 696.72 | 348.36 | n/a | n/a |
Other Expenses | -0.00 | -0.00 | -0.00 | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 33.04K | 28.09K | 23.14K | 21.36K | 19.58K | 18.72K | 17.86K | 18.98K | 20.1K | 20.99K | 21.88K | 19.55K | 17.22K | 11.99K | 6.74K | 3.66K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 4.48K | 4.06K | 3.65K | 3.14K | 2.64K | 2.65K | 2.65K | 2.85K | 3.04K | 3.12K | 3.21K | 2.39K | 1.57K | 890.78 | 200.48 | 168.19 |
Cost & Expenses | 33.04K | 28.09K | 23.14K | 21.36K | 19.58K | 18.72K | 17.86K | 18.98K | 20.1K | 20.99K | 21.88K | 19.55K | 17.22K | 11.99K | 6.75K | 3.66K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 27.06M | 27.06M | 22.58M | 21.39M | 20.99M | 20.99M | 19.02M | 19.02M | 14.59M | 14.59M | 13.7M | 13.7M | 13.2M | 13.2M | 13.2M | 13.2M |
Shares Outstanding (Diluted) | 27.06M | 27.06M | 22.58M | 21.39M | 20.99M | 20.99M | 19.02M | 19.02M | 14.59M | 14.59M | 13.72M | 13.72M | 13.2M | 13.2M | 13.2M | 13.2M |
EPS (Basic) | -0.6 | -0.3 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | n/a |
EPS (Diluted) | -0.6 | -0.3 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | n/a |
EBITDA | -32.59K | -27.52K | -22.45K | -20.68K | -18.96K | -18.28K | -17.59K | -18.72K | -19.83K | -20.84K | -21.86K | -16.97K | -12.08K | -6.86K | -1.62K | -1.09K |
EBIT | -33.04K | -27.83K | -22.62K | -20.86K | -19.1K | -18.38K | -17.66K | -18.76K | -19.85K | -20.86K | -21.87K | -16.97K | -12.08K | -6.86K | -1.62K | -1.1K |
Depreciation & Amortization | 454.43 | 309.24 | 164.05 | 177.15 | 141.29 | 105.44 | 69.58 | 33.73 | 25.56 | 17.39 | 9.22 | 0.81 | 0.57 | 0.33 | 5.13 | 10.84 |